New Key Statistics Module, Z-Score and F-Score
SHSE:603811 Key Ratios
Market Cap ¥ M | 2,667.53 |
Enterprise Value ¥ M | 2,761.53 |
P/E(ttm) | 15.98 |
PE Ratio without NRI | 15.67 |
Forward PE Ratio | -- |
Price/Book | 2.14 |
Price/Sales | 3.59 |
Price/Free Cash Flow | 25.38 |
Price/Owner Earnings | 57.38 |
Payout Ratio % | 0.38 |
Revenue (TTM) ¥ M | 732.00 |
EPS (TTM) ¥ | 0.51 |
Beneish M-Score | -2.09 |
10-y EBITDA Growth Rate % | 12.50 |
5-y EBITDA Growth Rate % | 13.50 |
y-y EBITDA Growth Rate % | 8.00 |
EV-to-EBIT | 13.96 |
EV-to-EBITDA | 13.96 |
PEG | 1.16 |
Shares Outstanding M | 327.30 |
Net Margin (%) | 22.66 |
Operating Margin % | 21.65 |
Pre-tax Margin (%) | 25.29 |
Quick Ratio | 1.01 |
Current Ratio | 1.38 |
ROA % (ttm) | 9.00 |
ROE % (ttm) | 13.82 |
ROIC % (ttm) | 9.22 |
Dividend Yield % | 2.44 |
Altman Z-Score | 4.11 |
SHSE:603811 Number of Guru Trades
SHSE:603811 Volume of Guru Trades
Gurus Latest Trades with SHSE:603811
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SHSE:603811 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Zhejiang Cheng Yi Pharmaceutical Co Ltd Insider Transactions
No Available Data